Cylindromatosis 1 Activators, also known as CYLD activators, represent a class of molecules with a unique role in cellular regulation and signaling pathways. At their core, CYLD activators play a pivotal role in the modulation of various cellular processes, primarily through the regulation of protein ubiquitination. Ubiquitination is a post-translational modification in which small proteins called ubiquitin are attached to target proteins, often marking them for degradation or altering their activity. CYLD activators specifically target the CYLD protein, which is a deubiquitinase enzyme responsible for removing ubiquitin chains from other proteins. By enhancing the activity of CYLD, these activators effectively fine-tune the ubiquitin-dependent signaling networks within cells.
The implications of CYLD activators are profound in the context of cellular homeostasis and immunity. They are involved in the negative regulation of various pathways, such as NF-κB signaling, which is critical in immune response and inflammation. By promoting the deubiquitination of key proteins in these pathways, CYLD activators exert a downregulatory effect, helping to attenuate excessive immune responses and maintain a balanced cellular environment. Furthermore, CYLD activators have been associated with the control of cell growth, differentiation, and apoptosis, making them essential players in cellular development and survival. These molecules are a subject of extensive research, as understanding their mechanisms of action can shed light on fundamental cellular processes and may have implications in various fields of biology and disease research.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Activates SIRT1, which deacetylates and upregulates CYLD. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Enhances CYLD expression via NF-κB inhibition. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Induces CYLD expression through glucocorticoid receptor activation. | ||||||
D,L-Sulforaphane | 4478-93-7 | sc-207495A sc-207495B sc-207495C sc-207495 sc-207495E sc-207495D | 5 mg 10 mg 25 mg 1 g 10 g 250 mg | $153.00 $292.00 $489.00 $1325.00 $8465.00 $933.00 | 22 | |
Activates Nrf2, which upregulates CYLD expression. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
Inhibits STAT3, leading to increased CYLD expression. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
HDAC inhibitor that increases CYLD gene expression. | ||||||
Berberine | 2086-83-1 | sc-507337 | 250 mg | $92.00 | 1 | |
Activates AMPK, which enhances CYLD expression. | ||||||
Quercetin | 117-39-5 | sc-206089 sc-206089A sc-206089E sc-206089C sc-206089D sc-206089B | 100 mg 500 mg 100 g 250 g 1 kg 25 g | $11.00 $17.00 $110.00 $250.00 $936.00 $50.00 | 33 | |
Inhibits NF-κB and STAT3, leading to CYLD upregulation. | ||||||
Thymoquinone | 490-91-5 | sc-215986 sc-215986A | 1 g 5 g | $47.00 $133.00 | 21 | |
Activates p38 MAPK, leading to increased CYLD expression. | ||||||
Rosiglitazone | 122320-73-4 | sc-202795 sc-202795A sc-202795C sc-202795D sc-202795B | 25 mg 100 mg 500 mg 1 g 5 g | $120.00 $326.00 $634.00 $947.00 $1259.00 | 38 | |
PPARγ agonist that upregulates CYLD gene expression. | ||||||